Stocktoria

CONMED Corp CNMD

NYSE · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1987-07-23 · LEI

CONMED Corp statistics & valuation

Market cap$1.1B
P / E23.0×
P / S0.8×
P / B1.0×
P / FCF7.2×
Dividend yield2.29%
Net margin3.4%
Return on equity4.6%
FCF margin11.0%
Return on capital5.1%
Graham number -32.2%$33.57

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($33.57); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
1.90% 7.00% 4.80% 3.00% 1.10% 6.20% -7.70% 5.20% 10.10% 3.40% 2016201720182019202020212022202320242025
Gross margin (%)
53.50% 54.10% 54.60% 54.90% 53.40% 56.20% 54.60% 54.30% 56.10% 54.60% 2016201720182019202020212022202320242025
Operating margin (%)
4.90% 5.90% 8.30% 8.30% 5.30% 10.90% 6.70% 9.70% 15.30% 7.50% 2016201720182019202020212022202320242025
Return on equity (%)
2.50% 8.80% 6.20% 4.00% 1.30% 8.00% -10.80% 7.70% 13.80% 4.60% 2016201720182019202020212022202320242025
Shares outstanding
28.0M 28.2M 28.9M 29.5M 29.5M 32.2M 30.0M 31.5M 31.1M 31.1M 2016201720182019202020212022202320242025
Net debt ($)
$471.1M $453.8M $439.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
1.10% 4.10% 3.00% 1.60% 0.50% 3.50% -3.50% 2.80% 5.70% 2.00% 2016201720182019202020212022202320242025
Free cash flow margin (%)
3.30% 6.60% 6.80% 7.90% 6.00% 9.60% 1.10% 8.50% 11.80% 11.00% 2016201720182019202020212022202320242025
Debt / equity (×)
0.86× 0.77× 0.69× 2016201720182019202020212022202320242025
EPS ($)
$0.52 $1.97 $1.41 $0.97 $0.32 $1.94 -$2.68 $2.04 $4.25 $1.51 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

CONMED Corp trades at about 32.8× earnings — below its 10-year norm (10-year range 16.9×–349.7×, median 49.9×).

16.9× 349.7×

Shaded band = 10-year range (16.9×–349.7×); dot = today's 32.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin54.6%56.1%54.3%54.6%56.2%53.4%54.9%54.6%54.1%53.5%
Operating margin7.5%15.3%9.7%6.7%10.9%5.3%8.3%8.3%5.9%4.9%
Net margin3.4%10.1%5.2%-7.7%6.2%1.1%3.0%4.8%7.0%1.9%
FCF margin11.0%11.8%8.5%1.1%9.6%6.0%7.9%6.8%6.6%3.3%
Return on assets2.0%5.7%2.8%-3.5%3.5%0.5%1.6%3.0%4.1%1.1%
Return on equity4.6%13.8%7.7%-10.8%8.0%1.3%4.0%6.2%8.8%2.5%
Debt / equity———————0.69×0.77×0.86×
Current ratio2.142.301.981.962.342.192.112.332.382.90

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.